The store will not work correctly when cookies are disabled.
3,3-diphenyl-1-(4-(piperidin-4-ylmethyl)piperazin-1-yl)propan-1-one
ID: ALA599425
PubChem CID: 46233646
Max Phase: Preclinical
Molecular Formula: C25H33N3O
Molecular Weight: 391.56
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CC(c1ccccc1)c1ccccc1)N1CCN(CC2CCNCC2)CC1
Standard InChI: InChI=1S/C25H33N3O/c29-25(28-17-15-27(16-18-28)20-21-11-13-26-14-12-21)19-24(22-7-3-1-4-8-22)23-9-5-2-6-10-23/h1-10,21,24,26H,11-20H2
Standard InChI Key: SMXYGIYCXXQYLV-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
1.5168 -1.2893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5168 -2.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8023 -2.5268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0879 -2.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0879 -1.2893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8023 -0.8768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8023 -3.3518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8023 -0.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0879 0.3607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0879 1.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6266 1.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8023 1.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6266 2.4232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3411 2.8357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0555 2.4232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0555 1.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3411 1.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8023 2.4232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5168 2.8357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2313 2.4232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2313 1.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5168 1.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5168 0.3607 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0879 -3.7643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0879 -4.5893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6266 -5.0018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3411 -4.5893 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3411 -3.7643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6266 -3.3518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 7 1 0
14 15 2 0
1 2 1 0
15 16 1 0
6 8 1 0
16 17 2 0
17 11 1 0
1 6 1 0
12 18 2 0
8 9 1 0
18 19 1 0
2 3 1 0
19 20 2 0
9 10 1 0
20 21 1 0
3 4 1 0
21 22 2 0
22 12 1 0
10 11 1 0
8 23 2 0
24 25 1 0
4 5 1 0
10 12 1 0
5 6 1 0
11 13 2 0
13 14 1 0
24 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
7 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 391.56 | Molecular Weight (Monoisotopic): 391.2624 | AlogP: 3.35 | #Rotatable Bonds: 6 |
Polar Surface Area: 35.58 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.35 | CX LogP: 3.07 | CX LogD: -0.54 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.82 | Np Likeness Score: -0.82 |
References
1. Pajouhesh H, Feng ZP, Ding Y, Zhang L, Pajouhesh H, Morrison JL, Belardetti F, Tringham E, Simonson E, Vanderah TW, Porreca F, Zamponi GW, Mitscher LA, Snutch TP.. (2010) Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors., 20 (4): [PMID:20117000] [10.1016/j.bmcl.2010.01.008] |